These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 29926227)
1. Sarcopenia in a mice model of chronic liver disease: role of the ubiquitin-proteasome system and oxidative stress. Campos F; Abrigo J; Aguirre F; Garcés B; Arrese M; Karpen S; Cabrera D; Andía ME; Simon F; Cabello-Verrugio C Pflugers Arch; 2018 Oct; 470(10):1503-1519. PubMed ID: 29926227 [TBL] [Abstract][Full Text] [Related]
2. Protective Effect of Angiotensin 1-7 on Sarcopenia Induced by Chronic Liver Disease in Mice. Aguirre F; Abrigo J; Gonzalez F; Gonzalez A; Simon F; Cabello-Verrugio C Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485991 [TBL] [Abstract][Full Text] [Related]
3. N-Acetyl Cysteine Attenuates the Sarcopenia and Muscle Apoptosis Induced by Chronic Liver Disease. Abrigo J; Marín T; Aguirre F; Tacchi F; Vilos C; Simon F; Arrese M; Cabrera D; Cabello-Verrugio C Curr Mol Med; 2019; 20(1):60-71. PubMed ID: 31530262 [TBL] [Abstract][Full Text] [Related]
4. Blockade of forkhead box protein O1 signaling alleviates primary sclerosing cholangitis-induced sarcopenia in mice model. Kim DH; Kim J; Park J; Kim TH; Han YH Life Sci; 2024 Nov; 356():123042. PubMed ID: 39233198 [TBL] [Abstract][Full Text] [Related]
5. Sarcopenia Induced by Chronic Liver Disease in Mice Requires the Expression of the Bile Acids Membrane Receptor TGR5. Abrigo J; Campos F; Gonzalez F; Aguirre F; Gonzalez A; Huerta-Salgado C; Conejeros S; Simon F; Arrese M; Cabrera D; Elorza AA; Cabello-Verrugio C Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33113850 [TBL] [Abstract][Full Text] [Related]
6. An ethanolic extract of Artemisia dracunculus L. regulates gene expression of ubiquitin-proteasome system enzymes in skeletal muscle: potential role in the treatment of sarcopenic obesity. Kirk-Ballard H; Kilroy G; Day BC; Wang ZQ; Ribnicky DM; Cefalu WT; Floyd ZE Nutrition; 2014; 30(7-8 Suppl):S21-5. PubMed ID: 24985101 [TBL] [Abstract][Full Text] [Related]
7. The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass. Rom O; Reznick AZ Free Radic Biol Med; 2016 Sep; 98():218-230. PubMed ID: 26738803 [TBL] [Abstract][Full Text] [Related]
8. Cholic acid and deoxycholic acid induce skeletal muscle atrophy through a mechanism dependent on TGR5 receptor. Abrigo J; Gonzalez F; Aguirre F; Tacchi F; Gonzalez A; Meza MP; Simon F; Cabrera D; Arrese M; Karpen S; Cabello-Verrugio C J Cell Physiol; 2021 Jan; 236(1):260-272. PubMed ID: 32506638 [TBL] [Abstract][Full Text] [Related]
9. High Fat Diet-Induced Skeletal Muscle Wasting Is Decreased by Mesenchymal Stem Cells Administration: Implications on Oxidative Stress, Ubiquitin Proteasome Pathway Activation, and Myonuclear Apoptosis. Abrigo J; Rivera JC; Aravena J; Cabrera D; Simon F; Ezquer F; Ezquer M; Cabello-Verrugio C Oxid Med Cell Longev; 2016; 2016():9047821. PubMed ID: 27579157 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle. Gonçalves DA; Lira EC; Baviera AM; Cao P; Zanon NM; Arany Z; Bedard N; Tanksale P; Wing SS; Lecker SH; Kettelhut IC; Navegantes LC Endocrinology; 2009 Dec; 150(12):5395-404. PubMed ID: 19837877 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin-(1-7) Prevents Skeletal Muscle Atrophy Induced by Transforming Growth Factor Type Beta (TGF-β) via Mas Receptor Activation. Ábrigo J; Simon F; Cabrera D; Cabello-Verrugio C Cell Physiol Biochem; 2016; 40(1-2):27-38. PubMed ID: 27842312 [TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor type beta (TGF-β) requires reactive oxygen species to induce skeletal muscle atrophy. Abrigo J; Rivera JC; Simon F; Cabrera D; Cabello-Verrugio C Cell Signal; 2016 May; 28(5):366-376. PubMed ID: 26825874 [TBL] [Abstract][Full Text] [Related]
16. An extract of Artemisia dracunculus L. inhibits ubiquitin-proteasome activity and preserves skeletal muscle mass in a murine model of diabetes. Kirk-Ballard H; Wang ZQ; Acharya P; Zhang XH; Yu Y; Kilroy G; Ribnicky D; Cefalu WT; Floyd ZE PLoS One; 2013; 8(2):e57112. PubMed ID: 23437325 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism. Cisternas F; Morales MG; Meneses C; Simon F; Brandan E; Abrigo J; Vazquez Y; Cabello-Verrugio C Clin Sci (Lond); 2015 Mar; 128(5):307-19. PubMed ID: 25222828 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas. Morales MG; Abrigo J; Acuña MJ; Santos RA; Bader M; Brandan E; Simon F; Olguin H; Cabrera D; Cabello-Verrugio C Dis Model Mech; 2016 Apr; 9(4):441-9. PubMed ID: 26851244 [TBL] [Abstract][Full Text] [Related]
19. Peroxynitrite induces degradation of myosin heavy chain via p38 MAPK and muscle-specific E3 ubiquitin ligases in C2 skeletal myotubes. Rom O; Kaisari S; Reznick AZ; Aizenbud D Adv Exp Med Biol; 2015; 832():1-8. PubMed ID: 25315626 [TBL] [Abstract][Full Text] [Related]
20. The ubiquitin-proteasome system and skeletal muscle wasting. Attaix D; Ventadour S; Codran A; Béchet D; Taillandier D; Combaret L Essays Biochem; 2005; 41():173-86. PubMed ID: 16250905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]